AwesomeAvani

NVAX pushed to bottom of its channel LONG

Long
AwesomeAvani Updated   
BATS:NVAX   Novavax, Inc.
NVAX powered off its earnings and a news catalyst and is overdue now for a correction. While in

an ascending channel NVAX is now at the bottom of the channel perhaps due to the general

market moves this week. From here it can move up in the channel or breakdown and fall into

a significant correction from the uptrend since May 10th. I am bullish on NVAX and have

a prior perspective of an insider. I have realized profit six figures from my call options for

January 2025 and have a large number remaining in the trade. At this juncture, I will watch

for NVAX to move up in the channel and take a trade of shares and some call options

for 15.00 expiring in June 2025 to take advantage of long term capital gains on the options.

The FDA is currently reviewing some COVID vaccine data which is particularly relevant to

NVAX. The volume profile has a shelf at 14.25 which will be my stop loss on the shares.

The options will have a 20% stop loss. Considering the level from which NVAX has fallen over

a period of some period there is great potential in my opinion.


Trade active:
NVAX moved up a little. The same 2% shaved off the stop loss which was raised.
Trade active:
As they say look to the left- my target for June 25 is %50.00 per share and 15X on the call options.

Comment:
and short squeeze will likely push price action and trend angle considerably.
Trade active:
Wider view chart with money flow and accumulation / distribution demonstrates

the quick up tick in money inflow and share accumulation as well as the Prive

Volume Trend momentum
Trade active:
Adds today in the early NY morning and after lunch. Nice momentum resumes !

Comment:
Bought the dip at two separate pivots. Targeting 17.00 to take a partial profit again.
Trade active:
Partial Profit taken at 18 and solid buying momentum moving price now.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.